List of serched triples

A total of 22252 records found

#18952 middle Confidence
Subject: Silvestrol (Small molecule drugs)
shows_antitumor_activity_in
Object: Liver cancer (Tumor diseases)
Original: Silvestrol#has shown#promising antitumor activity in breast cancer/ melanoma/ liver cancer/ and other tumor types
🏥 Therapeutic significance 📄 PMID: 38682208
#18951 middle Confidence
Subject: Silvestrol (Small molecule drugs)
shows_antitumor_activity_in
Object: Melanoma (Tumor diseases)
Original: Silvestrol#has shown#promising antitumor activity in breast cancer/ melanoma/ liver cancer/ and other tumor types
🏥 Therapeutic significance 📄 PMID: 38682208
#18950 middle Confidence
Subject: Silvestrol (Small molecule drugs)
shows_antitumor_activity_in
Object: Breast cancer (Tumor diseases)
Original: Silvestrol#has shown#promising antitumor activity in breast cancer/ melanoma/ liver cancer/ and other tumor types
🏥 Therapeutic significance 📄 PMID: 38682208
#18949 middle Confidence
Subject: Bone marrow-derived mesenchymal stem cells (Stem Cells)
inhibit
Object: progression_of_gastric_precancerous_lesions (Pathological process)
Original: Intravenous transplantation of BMMSCs#inhibited#the progression of precancerous gastric lesions
🏥 Therapeutic significance 📄 PMID: 38538255
#18948 middle Confidence
Subject: AgNORs_number_in_malignant_thyroid_lesions (Nuclear morphology)
exceeded
Object: AgNORs_number_in_benign_thyroid_lesions (Nuclear morphology)
Original: number of AgNORs in malignant thyroid lesions#exceeded#those in benign thyroid lesions
🏥 Diagnostic/prognostic significance 📄 PMID: 7739878
#18947 middle Confidence
Subject: S_methyl_methane_thiosulfonate (Compound)
prevents
Object: azoxymethane_induced_colon_carcinogenesis (Disease process)
Original: Dietary feeding of S-methyl methane thiosulfonate (MMTS)#prevents#azoxymethane-induced colon carcinogenesis
🏥 Preventive significance 📄 PMID: 7664279
#18946 middle Confidence
Subject: AgNOR_count_per_nucleus (Histological markers)
is_significantly_smaller_in
Object: AOM_d_limonene_treated_rats (Animal experiment group)
Original: AgNOR count/nucleus#is significantly smaller in#rats treated with AOM and d-limonene compared to AOM alone
🏥 not_specified 📄 PMID: 8625465
#18945 middle Confidence
Subject: biological_malignancy_pancreatic_carcinoma (Tumor Biology)
is_evaluated_by
Object: AgNOR_score (Histological markers)
Original: Biological malignancy of pancreatic carcinoma#is evaluated by#Ag-NOR score in resected specimens
🏥 Prognostic Assessment 📄 PMID: 9130343
#18944 middle Confidence
Subject: ras_p21 (Small G protein)
is_lower_in
Object: non_progressing_cases (Tumor cells)
Original: expression of ras p21#is greater in#progressing stage A cancer cells compared to non-progressing cases
🏥 Prognostic Assessment 🧬 RAS 📄 PMID: 7542162
#18943 middle Confidence
Subject: ras_p21 (Small G protein)
is_higher_in
Object: progressing_stage_A_cancer_cells (Tumor cells)
Original: expression of ras p21#is greater in#progressing stage A cancer cells compared to non-progressing cases
🏥 Prognostic Assessment 🧬 RAS 📄 PMID: 7542162
#18942 middle Confidence
Subject: proliferating_cell_nuclear_antigen (Proliferation-related proteins)
shows
Object: higher_proliferating_cell_fraction (Cell proliferation markers)
Original: proliferating cell nuclear antigen#shows#higher proliferating cell fraction in atypical and malignant meningiomas compared to benign meningiomas
🏥 Diagnosis/typing 📄 PMID: 9250918
#18941 middle Confidence
Subject: computer-assisted_image_analysis (Imaging analysis technology)
quantitates
Object: silver_staining_in_interphase_nuclei (staining signal)
Original: computer-assisted image analysis#quantitates#silver staining in interphase nuclei of bone marrow cells
🏥 Diagnostic analysis 📄 PMID: 2466799
#18940 middle Confidence
Subject: distinct_nucleoli (Prominent nucleoli)
correlates_with
Object: surgical_outcomes (Surgical Outcome)
Original: parameters like nuclear irregularity and distinct nucleoli#correlate with#surgical outcomes
🏥 Prognosis 📄 PMID: 37146190
#18939 middle Confidence
Subject: nuclear_irregularity (Nuclear irregularity)
correlates_with
Object: surgical_outcomes (Surgical Outcome)
Original: parameters like nuclear irregularity and distinct nucleoli#correlate with#surgical outcomes
🏥 Prognosis 📄 PMID: 37146190
#18938 middle Confidence
Subject: cytological_feature (Cytological characteristics)
is_statistically_significant_for
Object: grading (Tumor grade)
Original: six cytological features#were found to be#statistically significant for grading
🏥 diagnosis 📄 PMID: 14506669
#18937 middle Confidence
Subject: SNORA18L5 (Small nuclear RNA)
is_increased_in
Object: HCC_tissues (Tumor tissue)
Original: SNORA18L5#is increased in#HCC tissues compared with nontumor liver tissues
🏥 not_specified 🧬 SNORA18L5 📄 PMID: 29702115
#18936 middle Confidence
Subject: 15q13.3_duplication (Genome structural variation)
correlates_with
Object: SNORA18L5_expression_in_liver_tissues (RNA expression)
Original: 15q13.3 duplication#correlates with#SNORA18L5 expression in liver tissues
🏥 not_specified 🧬 SNORA18L5 📄 PMID: 29702115
#18935 middle Confidence
Subject: argyrophilic_nucleolar_organizer_regions (Molecular markers)
correlates_with
Object: prognosis_in_pancreatic_ductal_adenocarcinoma (Disease phenotype)
Original: Argyrophilic nucleolar organizer regions#correlate with#prognosis in ductal adenocarcinoma of the pancreas
🏥 Prognostic significance 📄 PMID: 8396611
#18934 middle Confidence
Subject: DMH_administration (Chemical inducers)
causes
Object: bile_duct_hyperplasia_with_inflammation (Bile duct hyperplasia with inflammation)
Original: DMH administration#causes#hepatic cell necrosis/ nodular areas/ and bile duct hyperplasia with inflammation
🏥 Pathological damage 📄 PMID: 12618326
#18933 middle Confidence
Subject: DMH_administration (Chemical inducers)
causes
Object: nodular_areas (Nodular area)
Original: DMH administration#causes#hepatic cell necrosis/ nodular areas/ and bile duct hyperplasia with inflammation
🏥 Pathological damage 📄 PMID: 12618326